ECE2017 Eposter Presentations: Pituitary and Neuroendocrinology Neuroendocrinology (33 abstracts)
Decreased prolactin levels in plasma and cerebrospinal fluid in naïve to treatment patients with multiple sclerosis
Agnieszka Baranowska-Bik 1 , Dorota Uchman 2 , Lidia Martynska 3 , Malgorzata Kalisz 3 , Anna Litwiniuk 3 , Wojciech Bik 3 , Boguslawa Baranowska 2 & Jan Kochanowski 2
1Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland; 2Department of Neurology, Medical University of Warsaw, Warsaw, Poland; 3Department of Neuroendocrinology, Centre of Postgraduate Medical Education, Warsaw, Portugal.
Background: Data from the literature has documented a remarkable immune-modulating role of prolactin. Previous evaluations of prolactin levels in patients with multiple sclerosis (MS), disease of autoimmune origin, showed conflicting results. Thus, to clarify the impact of prolactin on MS pathology we decided to assess prolactin levels in plasma and cerebrospinal fluid in naïve to treatment subjects with newly diagnosed MS.
Material and methods: A total number of 83 individuals were included: 41 patients with MS (30 females/11 males) and 42 age-matched controls (36 females/6 males). All MS subjects were newly diagnosed and they were without any treatment at the time of taking the samples of blood and cerebrospinal fluid. Prolactin was determined both in plasma and cerebrospinal fluid, and cytokines (TNF-alpha, IL-6, IL-10) were evaluated in plasma in all subjects.
Results: Prolactin levels in plasma were found to be markedly lower in MS patient when compared to those of the controls (7.64±5.99 ng/ml vs 10.12±6.76 ng/ml; P<0.05). These results correspond with concentration of prolactin measured in cerebrospinal fluid as in MS individuals prolactin was significantly decreased (2.84±0.35 ng/ml vs 3.42±0.89 ng/ml; P<0.05). The comparison of cytokines levels revealed no differences between the examined groups. A positive correlation between prolactin concentration in plasma and TNF-alpha levels was found in MS subjects.
Conclusion: Decreased levels of prolactin may reflect disturbed pituitary activity as well as disrupt immunological system regulation at the early stage of multiple sclerosis.
Acknowledgment: The study was supported with CMKP grant no.501-1-31-22-2015.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more